Published in Curr Opin Chem Biol on March 18, 2010
Dual catalysis. Single-electron transmetalation in organoboron cross-coupling by photoredox/nickel dual catalysis. Science (2014) 2.68
The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One (2013) 2.43
Single-electron transmetalation: an enabling technology for secondary alkylboron cross-coupling. J Am Chem Soc (2015) 1.56
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife (2014) 1.44
Synthesis and diversification of 1,2,3-triazole-fused 1,4-benzodiazepine scaffolds. Org Lett (2011) 1.34
Novel pyrrolopyrimidine-based α-helix mimetics: cell-permeable inhibitors of protein−protein interactions. J Am Chem Soc (2011) 1.29
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets. Proc Natl Acad Sci U S A (2012) 1.28
Facile and unified approach to skeletally diverse, privileged scaffolds. Org Lett (2011) 1.15
Multicomponent assembly strategies for the synthesis of diverse tetrahydroisoquinoline scaffolds. Org Lett (2011) 1.12
Base-Free Photoredox/Nickel Dual-Catalytic Cross-Coupling of Ammonium Alkylsilicates. J Am Chem Soc (2015) 1.10
Multicomponent assembly and diversification of novel heterocyclic scaffolds derived from 2-arylpiperidines. Org Lett (2011) 1.09
Cyclosulfamide-based derivatives as inhibitors of noroviruses. Eur J Med Chem (2011) 1.03
Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions. Bioorg Med Chem (2012) 1.03
The Molecule Cloud - compact visualization of large collections of molecules. J Cheminform (2012) 1.03
Nickel-catalyzed cross-coupling of chromene acetals and boronic acids. Org Lett (2012) 1.01
Solid-phase synthesis and chemical space analysis of a 190-membered alkaloid/terpenoid-like library. Proc Natl Acad Sci U S A (2011) 0.99
Synthesis of atropisomerically defined, highly substituted biaryl scaffolds through catalytic enantioselective bromination and regioselective cross-coupling. Angew Chem Int Ed Engl (2011) 0.97
Neurotrophic natural products: chemistry and biology. Angew Chem Int Ed Engl (2013) 0.96
Application of a sequential multicomponent assembly process/huisgen cycloaddition strategy to the preparation of libraries of 1,2,3-triazole-fused 1,4-benzodiazepines. ACS Comb Sci (2012) 0.94
Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum. Malar J (2014) 0.94
Inhibition of noroviruses by piperazine derivatives. Bioorg Med Chem Lett (2011) 0.93
Direct, catalytic, and regioselective synthesis of 2-alkyl-, aryl-, and alkenyl-substituted N-heterocycles from N-oxides. Org Lett (2014) 0.93
APPLICATIONS OF MULTICOMPONENT ASSEMBLY PROCESSES TO THE FACILE SYNTHESES OF DIVERSELY FUNCTIONALIZED NITROGEN HETEROCYCLES. Heterocycles (2011) 0.92
Expedient synthesis of norbenzomorphan library via multicomponent assembly process coupled with ring-closing reactions. ACS Comb Sci (2012) 0.89
Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma. Sci Rep (2014) 0.89
Identification of a new scaffold for hsp90 C-terminal inhibition. ACS Med Chem Lett (2013) 0.89
An allenic Pauson-Khand approach to 6,12-guaianolides. Org Lett (2011) 0.88
Competitive binding of a benzimidazole to the histone-binding pocket of the Pygo PHD finger. ACS Chem Biol (2014) 0.87
Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach. Mol Cancer Ther (2013) 0.87
Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents. Curr Med Chem (2015) 0.87
Privileged diazepine compounds and their emergence as bromodomain inhibitors. Chem Biol (2014) 0.86
2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study. Bioorg Med Chem Lett (2011) 0.86
Aminoboration: Addition of B-N σ Bonds across C-C π Bonds. J Am Chem Soc (2015) 0.86
Multicomponent synthesis of diverse 1,4-benzodiazepine scaffolds. Org Lett (2012) 0.85
Simultaneous synthesis of both rings of chromenes via a benzannulation/o-quinone methide formation/electrocyclization cascade. J Am Chem Soc (2011) 0.85
Large-scale chemical similarity networks for target profiling of compounds identified in cell-based chemical screens. PLoS Comput Biol (2015) 0.84
The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity. ACS Med Chem Lett (2012) 0.83
Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study. Bioorg Med Chem (2012) 0.83
Chiral amine synthesis using ω-transaminases: an amine donor that displaces equilibria and enables high-throughput screening. Angew Chem Int Ed Engl (2014) 0.83
DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction Sites. J Med Chem (2015) 0.82
An (R)-Imine Reductase Biocatalyst for the Asymmetric Reduction of Cyclic Imines. ChemCatChem (2015) 0.82
Integration of Microfractionation, qNMR and zebrafish screening for the in vivo bioassay-guided isolation and quantitative bioactivity analysis of natural products. PLoS One (2013) 0.82
Evolution of a strategy for preparing bioactive small molecules by sequential multicomponent assembly processes, cyclizations, and diversification. Org Biomol Chem (2014) 0.82
Synthesis of stereochemically and skeletally diverse fused ring systems from functionalized C-glycosides. J Org Chem (2013) 0.82
Multicomponent assembly processes for the synthesis of diverse yohimbine and corynanthe alkaloid analogues. ACS Comb Sci (2013) 0.81
Druggable chemical space and enumerative combinatorics. J Cheminform (2013) 0.79
Shape-based virtual screening with volumetric aligned molecular shapes. J Comput Chem (2014) 0.79
Mechanism for phenanthridines synthesis by nitrogenation of 2-acetylbiphenyls in acidic solution: a DFT study. J Mol Model (2016) 0.79
Ligand and Target Discovery by Fragment-Based Screening in Human Cells. Cell (2017) 0.79
Photoredox-mediated Minisci C-H alkylation of N-heteroarenes using boronic acids and hypervalent iodine. Chem Sci (2016) 0.78
A cycloisomerization/Friedel-Crafts alkylation strategy for the synthesis of pyrano[3,4-b]indoles. Org Lett (2011) 0.78
Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase. Bioorg Med Chem (2012) 0.78
Discovery of a Potent Anti-tumor Agent through Regioselective Mono-N-acylation of 7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine. Medchemcomm (2013) 0.78
A chemo-centric view of human health and disease. Nat Commun (2014) 0.78
A chemical family-based strategy for uncovering hidden bioactive molecules and multicomponent interactions in herbal medicines. Sci Rep (2016) 0.77
Metal-free C-H alkylation of heteroarenes with alkyltrifluoroborates: a general protocol for 1°, 2° and 3° alkylation. Chem Sci (2017) 0.77
Synthesis and biological activities of the respiratory chain inhibitor aurachin D and new ring versus chain analogues. Beilstein J Org Chem (2013) 0.77
Mini-ISES identifies promising carbafructopyranose-based salens for asymmetric catalysis: Tuning ligand shape via the anomeric effect. Sci Adv (2015) 0.77
Drug discovery: Diversifying complexity. Nat Chem (2013) 0.77
Multicomponent, Mannich-type assembly process for generating novel, biologically-active 2-arylpiperidines and derivatives. Tetrahedron (2014) 0.77
Scalable Synthesis of Piperazines Enabled by Visible-Light Irradiation and Aluminum Organometallics. Angew Chem Int Ed Engl (2015) 0.76
Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor. Bioorg Med Chem Lett (2014) 0.76
Visible-Light-Mediated Generation of Nitrogen-Centered Radicals: Metal-Free Hydroimination and Iminohydroxylation Cyclization Reactions. Angew Chem Int Ed Engl (2015) 0.76
Pharmacologic profiling of phosphoinositide 3-kinase inhibitors as mitigators of ionizing radiation-induced cell death. J Pharmacol Exp Ther (2013) 0.76
Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology. Future Med Chem (2016) 0.76
Structure-Based Scaffold Repurposing for G Protein-Coupled Receptors: Transformation of Adenosine Derivatives into 5HT2B/5HT2C Serotonin Receptor Antagonists. J Med Chem (2016) 0.76
Highly Efficient Cascade Reaction for Selective Formation of Spirocyclobutenes from Dienallenes via Palladium-Catalyzed Oxidative Double Carbocyclization-Carbonylation-Alkynylation. J Am Chem Soc (2016) 0.75
Method for Accessing Nitrogen-Containing, B-Heteroaryl-Substituted 2,1-Borazaronaphthalenes. J Org Chem (2016) 0.75
A simple one-pot 2-step N-1-alkylation of indoles with α-iminoketones toward the expeditious 3-step synthesis of N-1-quinoxaline-indoles. Tetrahedron Lett (2013) 0.75
Amide-controlled, one-pot synthesis of tri-substituted purines generates structural diversity and analogues with trypanocidal activity. Sci Rep (2015) 0.75
Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites. ACS Med Chem Lett (2017) 0.75
Enantioselective, Copper-Catalyzed Alkynylation of Ketimines To Deliver Isoquinolines with α-Diaryl Tetrasubstituted Stereocenters. Org Lett (2016) 0.75
Organocatalytic, enantioselective synthesis of benzoxaboroles via Wittig/oxa-Michael reaction Cascade of α-formyl boronic acids. Chem Sci (2017) 0.75
Crystal structures of ethyl 6-(4-methyl-phen-yl)-4-oxo-4H-chromene-2-carboxyl-ate and ethyl 6-(4-fluoro-phen-yl)-4-oxo-4H-chromene-2-carboxyl-ate. Acta Crystallogr E Crystallogr Commun (2016) 0.75
A simple copper-catalyzed two-step one-pot synthesis of indolo[1,2-a]quinazoline. Beilstein J Org Chem (2014) 0.75
Active machine learning-driven experimentation to determine compound effects on protein patterns. Elife (2016) 0.75
The chemistry and pharmacology of privileged pyrroloquinazolines. Medchemcomm (2015) 0.75
Synthesis of enones, pyrazolines and pyrrolines with gem-difluoroalkyl side chains. Beilstein J Org Chem (2013) 0.75
Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site. Sci Rep (2017) 0.75
Site-selective Suzuki-Miyaura coupling of heteroaryl halides - understanding the trends for pharmaceutically important classes. Chem Sci (2016) 0.75
Structure-Based Screening of Uncharted Chemical Space for Atypical Adenosine Receptor Agonists. ACS Chem Biol (2016) 0.75
Anti-Mycobacterial Evaluation of 7-Chloro-4-Aminoquinolines and Hologram Quantitative Structure-Activity Relationship (HQSAR) Modeling of Amino-Imino Tautomers. Pharmaceuticals (Basel) (2017) 0.75
A novel quinazolinone derivative induces cytochrome c interdependent apoptosis and autophagy in human leukemia MOLT-4 cells. Toxicol Rep (2014) 0.75
A novel dihydrocoumarin under experimental and theoretical characterization. J Mol Model (2017) 0.75
Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis. Chem Rev (2017) 0.75
Polypharmacology of conformationally locked methanocarba nucleosides. Drug Discov Today (2017) 0.75
Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov (2006) 15.21
The evolving role of natural products in drug discovery. Nat Rev Drug Discov (2005) 7.18
Target-oriented and diversity-oriented organic synthesis in drug discovery. Science (2000) 5.72
A planning strategy for diversity-oriented synthesis. Angew Chem Int Ed Engl (2004) 4.21
Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat Chem Biol (2005) 3.72
Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet (2000) 3.64
Towards the optimal screening collection: a synthesis strategy. Angew Chem Int Ed Engl (2008) 3.53
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science (1998) 3.53
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem (1988) 3.04
Exploring biology with small organic molecules. Nature (2004) 2.33
From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. Angew Chem Int Ed Engl (2002) 2.03
Privileged structures as leads in medicinal chemistry. Curr Med Chem (2006) 1.83
Privileged structures: applications in drug discovery. Comb Chem High Throughput Screen (2004) 1.82
Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res (2005) 1.67
Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J Comb Chem (2001) 1.49
Privileged molecules for protein binding identified from NMR-based screening. J Med Chem (2000) 1.40
Structural simplification of bioactive natural products with multicomponent synthesis. 2. antiproliferative and antitubulin activities of pyrano[3,2-c]pyridones and pyrano[3,2-c]quinolones. J Med Chem (2008) 1.28
Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem (2007) 1.28
Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem Biol (1999) 1.26
Medicinal chemistry of target family-directed masterkeys. Drug Discov Today (2003) 1.24
Rhodanine as a privileged scaffold in drug discovery. Curr Med Chem (2009) 1.23
From nature to drug discovery: the indole scaffold as a 'privileged structure'. Mini Rev Med Chem (2009) 1.17
Libraries from natural product-like scaffolds. Curr Opin Chem Biol (2004) 1.15
Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries. Nat Prod Rep (2008) 1.15
The chemodiversity of purine as a constituent of natural products. Chem Biodivers (2004) 1.12
Et2SBrSbCl5Br: an effective reagent for direct bromonium-induced polyene cyclizations. Angew Chem Int Ed Engl (2009) 1.09
The principle of complementarity: chemical versus biological space. Curr Opin Chem Biol (2005) 1.07
Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. J Med Chem (2010) 1.06
The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library. Proc Natl Acad Sci U S A (1994) 1.02
Natural compounds: leads or ideas? Bioinspired molecules for drug discovery. Chem Biol Drug Des (2008) 0.96
Diversity-oriented synthesis of privileged benzopyranyl heterocycles from s-cis-enones. J Org Chem (2008) 0.96
Chemical proteomics-based drug design: target and antitarget fishing with a catechol-rhodanine privileged scaffold for NAD(P)(H) binding proteins. J Med Chem (2008) 0.93
The proapoptotic benzodiazepine Bz-423 affects the growth and survival of malignant B cells. Cancer Res (2003) 0.91
2-Arylbenzothiazole as a privileged scaffold in drug discovery. Curr Med Chem (2009) 0.88
Discovery of estrogen sulfotransferase inhibitors from a purine library screen. J Med Chem (2001) 0.86
Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists. J Med Chem (1997) 0.86
Discovery of indoline-based, natural-product-like compounds as probes of focal adhesion kinase signaling pathways. J Comb Chem (2009) 0.86
Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors. Bioorg Med Chem Lett (2002) 0.85
Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents. Bioorg Med Chem (2009) 0.84
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituent. Bioorg Med Chem Lett (2001) 0.83
Combinatorial library synthesis and biological evaluation of pyrazolo[4,3-e][1,4]diazepine as a potential privileged structure. ChemMedChem (2009) 0.82
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81
Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell (2012) 6.31
The Diels--Alder reaction in total synthesis. Angew Chem Int Ed Engl (2002) 5.22
Conserved pathways within bacteria and yeast as revealed by global protein network alignment. Proc Natl Acad Sci U S A (2003) 4.68
Multicomponent therapeutics for networked systems. Nat Rev Drug Discov (2005) 3.99
Systematic discovery of multicomponent therapeutics. Proc Natl Acad Sci U S A (2003) 3.86
Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation. Nat Genet (2004) 3.84
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell (2003) 3.23
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature (2007) 3.21
PathBLAST: a tool for alignment of protein interaction networks. Nucleic Acids Res (2004) 3.20
Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv (2011) 2.57
Chemical combination effects predict connectivity in biological systems. Mol Syst Biol (2007) 2.42
Chasing molecules that were never there: misassigned natural products and the role of chemical synthesis in modern structure elucidation. Angew Chem Int Ed Engl (2005) 2.35
An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell (2013) 2.30
Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol (2008) 2.04
Combination chemical genetics. Nat Chem Biol (2008) 1.98
Tandem reactions, cascade sequences, and biomimetic strategies in total synthesis. Chem Commun (Camb) (2003) 1.91
Towards patient-based cancer therapeutics. Nat Biotechnol (2010) 1.63
Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins. Nat Chem Biol (2010) 1.62
Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc (2014) 1.49
Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens. Proc Natl Acad Sci U S A (2004) 1.48
Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem Biol (2004) 1.45
Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc Natl Acad Sci U S A (2011) 1.45
Clinical response to varying the stimulus parameters in deep brain stimulation for essential tremor. Mov Disord (2006) 1.39
Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans. PLoS One (2007) 1.25
Biological mechanism profiling using an annotated compound library. Chem Biol (2003) 1.23
Durability of implanted electrodes and leads in an upper-limb neuroprosthesis. J Rehabil Res Dev (2004) 1.20
Protein folding drives disulfide formation. Cell (2012) 1.18
Chemistry and biology of diazonamide A: second total synthesis and biological investigations. J Am Chem Soc (2004) 1.16
Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest. Genome Biol (2008) 1.15
A flexible data analysis tool for chemical genetic screens. Chem Biol (2004) 1.15
Biologically active molecules that reduce polyglutamine aggregation and toxicity. Hum Mol Genet (2006) 1.14
Chemistry and biology of diazonamide A: first total synthesis and confirmation of the true structure. J Am Chem Soc (2004) 1.11
Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg Med Chem Lett (2011) 1.10
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol (2013) 1.07
Detecting spatial patterns in biological array experiments. J Biomol Screen (2003) 1.06
Inhibitors of metabolism rescue cell death in Huntington's disease models. Proc Natl Acad Sci U S A (2007) 1.02
Functional model of metabolite gating by human voltage-dependent anion channel 2. Biochemistry (2011) 1.00
Total synthesis of diazonamide A. Angew Chem Int Ed Engl (2002) 1.00
Selective inhibitors of death in mutant huntingtin cells. Nat Chem Biol (2006) 0.99
Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries. RNA (2006) 0.99
The second total synthesis of diazonamide A. Angew Chem Int Ed Engl (2003) 0.99
Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency. ACS Med Chem Lett (2011) 0.98
Advances in chemical genetics. Annu Rev Genomics Hum Genet (2005) 0.97
The essence of total synthesis. Proc Natl Acad Sci U S A (2004) 0.96
Using small molecules to overcome drug resistance induced by a viral oncogene. Cancer Cell (2006) 0.96
Studies toward diazonamide A: initial synthetic forays directed toward the originally proposed structure. J Am Chem Soc (2004) 0.95
Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assay. Cancer Discov (2011) 0.94
Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death. Bioorg Med Chem Lett (2012) 0.92
Gene expression-based screening for inhibitors of PDGFR signaling. Genome Biol (2008) 0.92
Identifying druggable disease-modifying gene products. Curr Opin Chem Biol (2009) 0.91
9-Membered carbocycle formation: development of distinct Friedel-Crafts cyclizations and application to a scalable total synthesis of (±)-caraphenol A. Angew Chem Int Ed Engl (2014) 0.90
Eliminating membrane depolarization caused by the Alzheimer peptide Abeta(1-42, aggr.). Biochem Biophys Res Commun (2002) 0.89
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem Biol (2015) 0.89
Harnessing quinone methides: total synthesis of (±)-vaticanol A. Angew Chem Int Ed Engl (2014) 0.87
Global analysis of large-scale chemical and biological experiments. Curr Opin Drug Discov Devel (2002) 0.85
High throughput screening for neurodegeneration and complex disease phenotypes. Comb Chem High Throughput Screen (2008) 0.84
Therapeutic approaches to preventing cell death in Huntington disease. Prog Neurobiol (2012) 0.84
Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway. J Biol Chem (2010) 0.84
Restoring functions of tumor suppressors with small molecules. Cancer Cell (2003) 0.83
Chemical genetic approaches to probing cell death. Curr Opin Chem Biol (2006) 0.83
A concise total synthesis of (+)-scholarisine A empowered by a unique C-H arylation. J Am Chem Soc (2013) 0.83
Evaluation of command algorithms for control of upper-extremity neural prostheses. IEEE Trans Neural Syst Rehabil Eng (2002) 0.82
Subtrochanteric fixation stability depends on discrete fracture surface points. Clin Orthop Relat Res (2005) 0.82
Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials. J Endovasc Ther (2014) 0.81
Chemical genetics and orphan genetic diseases. Chem Biol (2005) 0.81
New uses for the Burgess reagent in chemical synthesis: methods for the facile and stereoselective formation of sulfamidates, glycosylamines, and sulfamides. Chemistry (2004) 0.81
A novel role for jun N-terminal kinase signaling in olfactory sensory neuronal death. Mol Cell Neurosci (2008) 0.80
Endovascular aortic aneurysm repair with the Zenith endograft in patients with ectatic iliac arteries. Ann Vasc Surg (2005) 0.80
An efficient approach to the securinega alkaloids empowered by cooperative N-heterocyclic carbene/Lewis acid catalysis. Angew Chem Int Ed Engl (2013) 0.80
Studies toward diazonamide A: development of a hetero-pinacol macrocyclization cascade for the construction of the bis-macrocyclic framework of the originally proposed structure. J Am Chem Soc (2004) 0.79
A strategy for complex dimer formation when biomimicry fails: total synthesis of ten coccinellid alkaloids. J Am Chem Soc (2014) 0.78
Identification of a small molecule that induces ATG5-and-cathepsin-l-dependent cell death and modulates polyglutamine toxicity. Exp Cell Res (2013) 0.78
A novel regio- and stereoselective synthesis of sulfamidates from 1,2-diols using Burgess and related reagents: a facile entry into beta-amino alcohols. Angew Chem Int Ed Engl (2002) 0.78
A new method for the synthesis of nonsymmetrical sulfamides using burgess-type reagents. Angew Chem Int Ed Engl (2002) 0.78
Factors predictive of early or late aneurysm sac size change following endovascular repair. J Vasc Surg (2006) 0.78
A mammalian cell-based assay for screening inhibitors of RNA cleavage. Methods Mol Biol (2009) 0.77
Drug discovery: engineering drug combinations. Nat Chem Biol (2010) 0.77
Organic chemistry: Symmetrizing the unsymmetrical. Nature (2010) 0.77
Chemical biology: renewing embryonic stem cells. Nature (2006) 0.77
Small molecule screen reveals regulation of survival motor neuron protein abundance by Ras proteins. ACS Chem Biol (2013) 0.76
A new method for the stereoselective synthesis of alpha- and beta-glycosylamines using the Burgess reagent. J Am Chem Soc (2004) 0.76
Enzyme annotation with chemical tools. Chem Biol (2006) 0.75
Evaluation of HIV-1 inhibition by stereoisomers and analogues of the sesquiterpenoid hydroquinone peyssonol A. Bioorg Med Chem Lett (2013) 0.75
Syntheses of cyclotriveratrylene analogues and their long elusive triketone congeners. Org Lett (2014) 0.75
The biological magic behind the bullets. Nat Biotechnol (2004) 0.75
Discovery of Anticancer Agents of Diverse Natural Origin. J Nat Prod (2022) 0.75
The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow. Drug Discov Today (2009) 0.75
Explorations of caffeic acid derivatives: total syntheses of rufescenolide, yunnaneic acids C and D, and studies toward yunnaneic acids A and B. J Org Chem (2013) 0.75